U.S. Consumer Durables Stock News

Insulet has launched its Omnipod 5 Automated Insulin Delivery System in selected Middle Eastern markets. The company also introduced Omnipod Discover, a new data and analytics platform for diabetes management. Both products expand Insulet's global footprint and broaden its connected product ecosystem around Omnipod. Insulet, traded as NasdaqGS:PODD, is adding fresh product news at a time when its share price is $243.15. The stock has seen a 17.4% decline over the past 30 days and a 15.5%...

If you are wondering whether Summit Therapeutics at around US$13.85 is pricing in too much hope or not enough, you are in the right place for a clear look at what the market might be implying about its value. The share price has seen sharp swings, with a 10.1% decline over the past week, a 25.8% decline over the past month, a 20.9% decline year to date, yet a very large gain over three years and an 87.9% gain over five years. These moves have come as Summit Therapeutics continues to attract...

Investors wondering whether Nextpower is still fairly priced after a strong run, or if the share price has moved ahead of the underlying value, will find that this article focuses squarely on what the current valuation might be indicating. The stock recently closed at US$114.44, with a 30 day return of 25.1% and a 1 year return of 140.4%. Over the last 7 days, however, the share price has pulled back 5.5%, which may reflect some reassessment of risk or profit taking after a 23.3% year to...

Innodata (NasdaqGM:INOD) has entered into a partnership with Palantir to provide specialized data engineering and annotation for advanced AI projects. The collaboration focuses on complex, real world use cases, including video annotation and multimodal generative AI workflows for performance analytics in ride event analysis. The agreement positions Innodata as a key data partner for high stakes AI deployments where quality, security and domain specific workflows are central...

If you are wondering whether Lear’s current share price really reflects its underlying value, you are not alone. This article is designed to help you frame that question clearly. Lear’s share price recently closed at US$136.05, with returns of 12.8% over the last 7 days, 10.2% over 30 days, 14.7% year to date, 48.3% over 1 year, 6.6% over 3 years, and a 5.1% decline over 5 years. Recent attention on Lear has been shaped by company updates and sector headlines that have put auto related...

If you are wondering whether MetLife's current share price reflects its true worth, you are not alone. That is exactly what this valuation focused review aims to unpack. MetLife recently closed at US$75.32, with returns of 3.7% decline over 7 days, 7.2% decline over 30 days, 6.2% decline year to date and 7.3% decline over 1 year, compared with longer term returns of 16.8% over 3 years and 58.5% over 5 years. Recent attention around MetLife has centered on its position as a large, established...

Corteva (NYSE:CTVA) has reached a comprehensive settlement with Bayer that resolves all "freedom to operate" litigation between the two companies. The agreement is expected to support Corteva's corn licensing activities and open a path into the cotton licensing market. Separately, Corteva is moving ahead with a planned separation of its seed operations into a standalone company. The spin off may include relocating the new seed company headquarters to Iowa, with implications for regional...

Apellis Pharmaceuticals (APLS) has just been added to the S&P 1000, S&P 600, S&P 600 Health Care Sector, and S&P Composite 1500, a shift that can influence trading as index trackers rebalance. See our latest analysis for Apellis Pharmaceuticals. Those index additions come after a mixed share price run, with a 90 day share price return of 17.13% contrasting with a year to date share price decline of 12.76% and a 1 year total shareholder return decline of 25.30%. This suggests recent momentum...

Morningstar’s new private markets indexes Morningstar (MORN) is drawing fresh attention after working with PitchBook to launch indexes that track semiliquid funds investing in private markets, giving investors a new reference point for these vehicles. See our latest analysis for Morningstar. The index launch comes at a time when Morningstar’s share price has been under pressure, with a 7 day share price return of 16.25% and a 30 day share price return of 20.82%. At the same time, the 1 year...

Regal Rexnord (RRX) has wrapped up FY 2025 with fourth quarter revenue of US$1.5 billion and basic EPS of US$0.96, alongside trailing twelve month revenue of US$5.9 billion and EPS of US$4.22 that sit against a 42.5% year over year earnings lift and a 23.4% earnings growth forecast over the next three years. Over recent periods the company has seen quarterly revenue move from US$1,461.1 million in Q4 FY 2024 to US$1,523.2 million in Q4 FY 2025, while basic EPS shifted from US$0.62 to US$0.96,...

Ralph Lauren (NYSE:RL) reported strong third quarter results, with broad-based performance across regions and product categories. The company raised its full-year outlook, reflecting confidence in current business trends. Management highlighted rapid adoption of advanced digital initiatives, including AI-powered shopping tools, and growth in new consumers and digital engagement. For investors watching Ralph Lauren at a share price of $338.66, the recent update comes after a mixed stretch,...

Why Pitney Bowes is on investors’ radar now Pitney Bowes (PBI) has drawn fresh attention after recent trading, with the share price around $10.58 and returns over the past 3 months and year standing out against its longer term record. See our latest analysis for Pitney Bowes. Recent trading has added to that focus, with a 90 day share price return of 12.20% and a 1 year total shareholder return of 25.87%. The 3 year total shareholder return of about 19x also stands out against its longer...

AI driven software sell off hits PagerDuty A sector wide pullback in software tied to concerns about artificial intelligence has hit PagerDuty (PD), with institutional investors rotating away from traditional SaaS names and the stock recently dropping 12.1% in a single session. PagerDuty is now down 28.3% this year, with shares trading near US$7.90. This move has sharply reset expectations around the company and put renewed focus on its role in modern digital operations. See our latest...

Standex International Corporation recently reported higher second-quarter fiscal 2026 sales of US$221.32 million and increased net income, reaffirmed its full-year 2026 revenue growth outlook of over US$110 million, completed a multi-year US$76.42 million share repurchase program, and announced a 6.3% higher quarterly dividend of US$0.34 per share. The company is emphasizing growth in fast-growth end markets such as aerospace, defense, and Grid, while investing in new capacity across...

SS&C Technologies Holdings, Inc. has reported its fourth-quarter 2025 results, with revenue rising to US$1,653.5 million while net income and earnings per share from continuing operations declined versus the prior year, alongside fresh client wins with Allspring Global Investments, Saltus and Rareview Capital across transfer agency and wealth/ETF platforms. The combination of stronger top-line performance and expanded long-term client relationships highlights how SS&C is deepening its role...

What Primerica’s recent performance numbers tell you Primerica (PRI) has drawn attention after recent share price moves, with the stock showing a return of 0.8% over the past day, about 3.7% over the past week, and 4.1% over the past month. Over longer periods, Primerica’s reported total returns are 7.5% for the past 3 months, 5.0% year to date, and a 6.9% decline over the past year, alongside multi year total returns that are described as very large. See our latest analysis for Primerica. At...

Phibro Animal Health Q2 2026 earnings snapshot Phibro Animal Health (PAHC) just posted Q2 2026 results with revenue of US$373.9 million and basic EPS of US$0.68, while trailing twelve month figures stand at US$1.5 billion in revenue and basic EPS of US$2.27. The company has seen quarterly revenue move from US$309.3 million in Q2 2025 to US$373.9 million in Q2 2026, with basic EPS shifting from US$0.08 to US$0.68 over the same period. This sets up a scenario where investors may weigh these...

Lantronix (LTRX) has just posted Q2 2026 results with revenue of about US$29.8 million and a basic EPS loss of roughly US$0.03, alongside trailing twelve month figures showing US$116.9 million in revenue and a basic EPS loss of about US$0.24. Over recent quarters the company has seen revenue move between US$28.5 million and US$34.4 million, while quarterly basic EPS has ranged from a loss of roughly US$0.10 to a loss of about US$0.03. This keeps the focus firmly on how efficiently each dollar...

Moelis (MC) has rounded out FY 2025 with fourth quarter revenue of US$487.9 million and basic EPS of US$1.19, setting the tone for a year in which trailing 12 month revenue reached about US$1.5 billion and EPS came in at US$3.11. The company reported an increase in revenue from US$438.7 million and EPS of US$1.27 in Q4 2024 to US$487.9 million and EPS of US$1.19 in Q4 2025, while trailing 12 month EPS moved from US$1.93 to US$3.11 over the same period. This provides investors with a snapshot...

Why Liquidity Services stock is back in focus Liquidity Services (LQDT) is back on investors’ radars after reporting its first quarter results and issuing earnings guidance for the fiscal second quarter of 2026, giving the market fresh profit and EPS ranges to assess. See our latest analysis for Liquidity Services. The earnings release and fresh guidance appear to have kept interest in Liquidity Services elevated, with a 90 day share price return of 45.35% and a 3 year total shareholder...

Monarch Casino & Resort (MCRI) has just wrapped up FY 2025 with fourth quarter revenue of US$140.0 million and basic EPS of US$1.27, while trailing twelve month figures show revenue of US$545.1 million and EPS of US$5.55, set against earnings growth of 39.3% over the past year. Over recent periods the company has seen revenue move from US$134.5 million in Q4 2024 to US$140.0 million in Q4 2025, with quarterly EPS shifting from US$0.23 to US$1.27 and trailing net profit margin sitting at 18.6%...

ECB Bancorp’s FY 2025 earnings step up as margins strengthen ECB Bancorp (ECBK) has just wrapped up FY 2025 with fourth quarter total revenue of US$9.3 million and basic EPS of US$0.32, supported by quarterly net income of US$2.6 million. The company has seen total revenue move from US$7.4 million in Q4 2024 to US$9.3 million in Q4 2025, while basic EPS has shifted from US$0.18 to US$0.32 over the same period, alongside trailing twelve month net income of US$7.8 million. For investors, the...

Why Clear Secure Is Suddenly in the Spotlight Clear Secure (YOU) has jumped up investors’ watchlists after a run of quarters where it beat both earnings and revenue expectations, drawing fresh media coverage and interest in its recent stock moves. See our latest analysis for Clear Secure. Despite a 44.92% total shareholder return over the past year, recent share price performance has cooled. The 30 day share price return is 9.30% and the 90 day share price return is 9.67%, which hints that...

In recent days, Asana reported past progress on tightening financial discipline and raised its full-year revenue and operating margin guidance while operating in a constrained growth backdrop. A key takeaway is Asana’s push into AI-powered offerings like AI Studio and AI Teammates, which could gradually shift its business toward a more consumption-oriented model less tied to traditional seat expansion. Next, we’ll examine how Asana’s focus on AI-driven products and evolving monetization...